The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease
Open accessAbstract
Frontotemporal lobar degeneration with TAR DNA-binding protein 43 inclusions (FTLD-TDP) is the most common pathology associated with frontotemporal dementia (FTD). Repeat expansions in chromosome 9 open reading frame 72 (C9ORF72) and mutations in progranulin (GRN) are the major known genetic causes of FTLD-TDP; however, the genetic etiology in the majority of FTLD-TDP remains unexplained. In this study, we performed whole-genome sequencing in 104 pathologically confirmed FTLD-TDP patients from the Mayo Clinic brain bank negative for C9ORF72 and GRN mutations and report on the contribution of rare single nucleotide and copy number variants in 21 known neurodegenerative disease genes. Interestingly, we identified 5 patients (4.8 %) with variants in optineurin (OPTN) and TANK-binding kinase 1 (TBK1) that are predicted to be highly pathogenic, including two double mutants. Case A was a compound heterozygote for mutations in OPTN, carrying the p.Q235* nonsense and p.A481V missense mutation in trans, while case B carried a deletion of OPTN exons 13-15 (p.Gly538Glufs*27) and a loss-of-function mutation (p.Arg117*) in TBK1. Cases C-E carried heterozygous missense mutations in TBK1, including the p.Glu696Lys mutation which was previously reported in two amyotrophic lateral sclerosis (ALS) patients and is located in the OPTN binding domain. Quantitative mRNA expression and protein analysis in cerebellar tissue showed a striking reduction of OPTN and/or TBK1 expression in 4 out of 5 patients supporting pathogenicity in these specific patients and suggesting a loss-of-function disease mechanism. Importantly, neuropathologic examination showed FTLD-TDP type A in the absence of motor neuron disease in 3 pathogenic mutation carriers. In conclusion, we highlight TBK1 as an important cause of pure FTLD-TDP, identify the first OPTN mutations in FTLD-TDP, and suggest a potential oligogenic basis for at least a subset of FTLD-TDP patients. Our data further add to the growing body of evidence linking ALS and FTD and suggest a key role for the OPTN/TBK1 pathway in these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Supporting the link between ALS and FTD, TBK1 mutations have also been identified in FTD patients, and in fact occur more frequently in patients with combined ALS-FTD than in those with ALS alone [207–209].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [209]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIH Image to ImageJ: 25 years of image analysis
Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 13×
“The most striking evidence, however, came from the identification of repeat expansions in C9ORF72 as a common cause of FTD, ALS and mixed FTD-ALS patients, which firmly established a genetic link between these disorders [14, 45].”
BackgroundInfluentialSelf-citationA Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationArai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C. A., Rogelj, B., Hortobágyi, T., Vos, K. J. D., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B. N., Ruddy, D., Wright, P. D., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,625
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J. M., Kasarskis, E. J., Munsat, T. L., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,624
Cited by
Sorted by citations
Items 201–300 of 312
Müller, C. P., Chu, C., Qin, L., Liu, C., Xu, B., Gao, H., Ruggeri, B., Hieber, S., Schneider, J., Jia, T., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy341 · Cited by 16
Beckers, J., & Damme, P. V. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2474796 · Cited by 19
TBK1 haploinsufficiency in ALS and FTD compromises membrane trafficking
Lu, Y., Almeida, S., & Gao, F. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02331-1 · Cited by 15
Saul, V. V., Seibert, M., Krüger, M., Jeratsch, S., Kracht, M., & Schmitz, M. L. (2019) · iScience · doi:10.1016/j.isci.2019.08.001 · Cited by 15
Primary progressive aphasias associated with C9orf72 expansions: Another side of the story
Saracino, D., Géraudie, A., Remes, A. M., Sophie Ferrieux, A., Nogues, M., Bottani, S., Cipriano, L., Houot, M., Funkiewiez, A., Camuzat, A., et al. (2021) · Cortex · doi:10.1016/j.cortex.2021.09.005 · Cited by 15
Rab-dependent cellular trafficking and amyotrophic lateral sclerosis
Parakh, S., Perri, E. R., Jagaraj, C. J., Ragagnin, A., & Atkin, J. D. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1553926 · Cited by 15
Immunological signatures in frontotemporal lobar degeneration
Sirkis, D. W., Bonham, L. W., Karch, C. M., & Yokoyama, J. S. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000665 · Cited by 14
Davis, S. E., Cook, A. K., Hall, J. A., Voskobiynyk, Y., Carullo, N. V. N., Boyle, N. R., Hakim, A. R., Anderson, K. M., Hobdy, K. P., Pugh, D. A., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01571-4 · Cited by 12
Association of the TBK1 mutation p.Ile334Thr with frontotemporal dementia and literature review
Yu, H., Yu, W., Luo, S., Yang, Y., Liu, F., Zhang, Y., Chen, Y., Sun, Y., & Wu, J. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.547 · Cited by 13
Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration
Giunta, M., Solje, E., Gardoni, F., Borroni, B., & Benussi, A. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s262352 · Cited by 15
Bruno, C., Sieverding, K., Freischmidt, A., Satoh, T., Walther, P., Mayer, B., Ludolph, A. C., Akira, S., Yilmazer‐Hanke, D., Danzer, K. M., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa133 · Cited by 14
Charting Frontotemporal Dementia: From Genes to Networks
Filippi, M., Agosta, F., & Ferraro, P. M. (2015) · Journal of Neuroimaging · doi:10.1111/jon.12316 · Cited by 14
The Underestimated Role of Iron in Frontotemporal Dementia: A Narrative Review
Ferretti, S., & Zanella, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312987 · Cited by 12
TBK1 variants in Chinese patients with amyotrophic lateral sclerosis
Liu, X., He, J., Chen, L., Zhang, N., Tang, L., Liu, X., Ma, Y., & Fan, D. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.07.028 · Cited by 12
Clayton, E. L., Bonnycastle, K., Isaacs, A. M., Cousin, M. A., & Schorge, S. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15551 · Cited by 12
ALS-linked CCNF variant disrupts motor neuron ubiquitin homeostasis
Farrawell, N. E., Bax, M., McAlary, L., McKenna, J. A., Maksour, S., Do‐Ha, D., Rayner, S. L., Blair, I. P., Chung, R. S., Yerbury, J. J., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad063 · Cited by 12
Cocoş, R., & Popescu, B. O. (2024) · Human Genomics · doi:10.1186/s40246-024-00704-7 · Cited by 17
Mullany, S., Marshall, H. N., Díaz‐Torres, S., Berry, E. C., Schmidt, J. M., Thomson, D., Qassim, A., To, M., Dimasi, D. P., Kuot, A., et al. (2022) · Ophthalmology Science · doi:10.1016/j.xops.2022.100159 · Cited by 11
Dominguez, J. C., Yu, J. G., Tan, Y. J., Ng, A. R., Guzman, M. F. D., Natividad, B. P., Daroy, M. L. G., Cano, J., Yu, J. M. F., Lian, M. M., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.645913 · Cited by 13
Giannoccaro, M. P., Bartoletti‐Stella, A., Piras, S., Casalena, A., Oppi, F., Ambrosetto, G., Montagna, P., Liguori, R., Parchi, P., & Capellari, S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170913 · Cited by 11
Review: Induced pluripotent stem cell models of frontotemporal dementia
Preza, E., Hardy, J., Warner, T. T., & Wray, S. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12334 · Cited by 10
Генетическое разнообразие лобно-височной деменции
Шпилюкова, Ю. А., Fedotova, E. Y., & Illarioshkin, S. N. (2020) · Molecular Biology · doi:10.31857/s0026898420010139 · Cited by 10
Lok, H. C., & Kwok, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052541 · Cited by 10
Impairments of inhibitory neurons in amyotrophic lateral sclerosis and frontotemporal dementia
Lorenc, F., Dupuis, L., & Cassel, R. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106748 · Cited by 9
Is pseudoexfoliation glaucoma a neurodegenerative disorder?
Padhy, B., & Alone, D. P. (2021) · Journal of Biosciences · doi:10.1007/s12038-021-00217-8 · Cited by 9
Novel Intronic Mutations of TBK1 Promote Aberrant Splicing Modes in Amyotrophic Lateral Sclerosis
Lu, Y., Chen, J., Han, L., Feng, S., Che, C., Liu, C.-Y., Huang, H., & Zou, Z. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.691534 · Cited by 9
Dong, S., Yin, X., Wang, K., Yang, W., Li, J., Wang, Y., Zhou, Y., Liu, X., Wang, J., & Chen, X. (2023) · Phenomics · doi:10.1007/s43657-022-00093-8 · Cited by 9
Sterile innate immune mechanisms in neurodegenerative diseases
Ealy, A., Serapiglia, A. M., & Panicker, N. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111039 · Cited by 8
TFEB overexpression alleviates autophagy-lysosomal deficits caused by progranulin insufficiency
Nader, W. O., Brown, K. S., Boyle, N. R., Kaplelach, A. K., Abdelaziz, S. M., Davis, S. E., Aljabi, Q., Hakim, A. R., Davidson, A. G., Vollmer, G. A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-12268-0 · Cited by 8
Smeyers, J., Osés-Prieto, J. A., Yadanar, L., Wang, M., Iadarola, M., Lu, S. H.-A., Wang, K. S., Watanabe, T. H., Debnath, J., Burlingame, A. L., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116494 · Cited by 8
No Strong Association between the Apolipoprotein E E4 Allele and Glaucoma
Mullany, S., Díaz‐Torres, S., Schmidt, J. M., Thomson, D., Qassim, A., Marshall, H. N., Knight, L. S. W., Berry, E. C., Kolovos, A., Dimasi, D. P., et al. (2023) · Ophthalmology Science · doi:10.1016/j.xops.2023.100287 · Cited by 7
Clinical Update on C9orf72: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, and Beyond
Saracino, D., & Ber, I. L. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_5 · Cited by 7
Gotkine, M., de Majo, M., Wong, C. H., Topp, S. D., Michaelson‐Cohen, R., Epsztejn‐Litman, S., Eiges, R., Lerner, Y., Kanaan, M. N., Shaked, H. M., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.05.009 · Cited by 7
Santamaría‐García, H. A., Ogonowski, N. S., Báez, S., Palacio, N., Reyes, P. A., Schulte, M., López, A., Matallana, D., & Ibáñez, A. M. (2022) · BMC Neurology · doi:10.1186/s12883-022-02954-1 · Cited by 17
Genetics of Frontotemporal Lobar Degeneration: From the Bench to the Clinic
Tang, S.-S., Li, J., Tan, L., & Yu, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160236 · Cited by 5
Seibert, K., Smith, H., Lapins, A., Pytel, P., & Mastrianni, J. A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.826676 · Cited by 6
Amyotrophic Lateral Sclerosis 1 and Many Diseases
Ratti, E., & Berry, J. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00042-1 · Cited by 5
Sullivan, P. M., Zhou, X., & Hu, F. (2017) · InTech eBooks · doi:10.5772/intechopen.69371 · Cited by 6
Role of the STING-IRF3 Pathway in Ambient GABA Homeostasis and Cognitive Function
Neupane, C., Sharma, R., Gao, F. F., Phạm, T. L., Kim, Y. S., Yoon, B., Jo, E., Sohn, K., Hur, G. M., Cha, G., et al. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1810-23.2024 · Cited by 5
Nolan, M., Barbagallo, P., Turner, M. R., Keogh, M. J., Chinnery, P. F., Talbot, K., & Ansorge, O. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325803 · Cited by 5
Frequency of frontotemporal dementia-related gene variants in Turkey
Artan, S., Gökalp, E. E., Samancı, B., Adapınar, D. Ö., Baş, H., Tepgeç, F., Ekenel, E. Q., Cilingir, O., Bılgıç, B., Gurvit, H. I., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.05.007 · Cited by 6
Phenotypic and genotypic features of patients diagnosed with ALS in the city of Sakarya, Turkey
Kotan, D., Ayas, Z. Ö., Tunca, C., Güngen, B. D., Akçimen, F., & Başak, A. N. (2020) · Acta Neurologica Belgica · doi:10.1007/s13760-020-01441-z · Cited by 6
Optineurin Dysfunction in Amyotrophic Lateral Sclerosis: Why So Puzzling?
Prtenjača, N. (2020) · Periodicum Biologorum · doi:10.18054/pb.v121-122i1-2.10627 · Cited by 5
Wauters, E., Sleegers, K., Cruts, M., & Broeckhoven, C. V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00009-9 · Cited by 6
Ghayal, N. B., Crook, R., Jain, A., Sachdeva, G. S., Jiang, P., Roemer, S. F., Sekiya, H., Deture, M. A., Baker, M., Coster, W. D., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02958-4 · Cited by 4
Self-citationMonogenic disorders of the TNF signalling pathway
Lalaoui, N., & Masters, S. L. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01327-5 · Cited by 6
Dickerson, B. C. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781316091586.016 · Cited by 4
Piaceri, I., Bessi, V., Matà, S., Polito, C., Tedde, A., Berti, V., Bagnoli, S., Braccia, A., Mastio, M. D., Pignone, A. M., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170694 · Cited by 4
First Case of Parkinsonian‐Pyramidal Syndrome Associated with a TBK1 Mutation
Santos‐García, D., Pozojevic, J., Fonticoba, T. D. D., Kurtis, M. M., Gámez, J., Klein, C., Monje, M. H. G., & Westenberger, A. (2020) · Movement Disorders · doi:10.1002/mds.28405 · Cited by 4
Li, C., Wen, Y., Zhao, M., Wang, Y., Li, P., Wang, L., & Wang, S. H. (2023) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2222 · Cited by 3
Dementia and cognitive decline
Huq, A. J., Eratne, D., & Velakoulis, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99417-0.00006-9 · Cited by 4
Herrera, M. G., Kühn, L., Jungbluth, L., Bader, V., Krause, L. J., Kartte, D., Adriaenssens, E., Martens, S., Tatzelt, J., Sachse, C., et al. (2025) · Advanced Science · doi:10.1002/advs.202509927 · Cited by 3
Understanding Neurodegenerative Diseases From the −Omics Perspective: Lessons Learnt
Ibáñez, L., Pottier, C. P., Beric, A., Western, D., Ali, M., & Cruchaga, C. (2026) · Annals of Neurology · doi:10.1002/ana.78170 · Cited by 6
Self-citationManganelli, F., Perfetto, C., Carletta, O., & Gerbino, V. (2026) · Cells · doi:10.3390/cells15050477 · Cited by 4
Degradation of Misfolded Proteins in Neurodegenerative Diseases: Therapeutic Targets and Strategies
Rajak, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-6202-9_17 · Cited by 3
Almaguer-Mederos, L. E., Kandi, A. R., Şen, N.-E., Canet-Pons, J., Berger, L.-M., Stokes, M. P., Abell, K., Key, J., Gispert, S., & Auburger, G. W. J. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101072 · Cited by 5
Inherited disorders of TLR, IL-1R, and NFκB immunity
Boisson, B., Zhang, S., Casanova, J., & Puel, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816768-7.00039-9 · Cited by 3
Novel TBK1 variant associated with Frontotemporal Dementia overlap syndrome
Arshad, F., Vengalil, S., Nalini, A., Polavarapu, K., Shamim, U., Jabeen, S., Nagaraj, C., Ramakrishnan, S., Faruq, M., & Alladi, S. (2021) · Acta Neurologica Scandinavica · doi:10.1111/ane.13562 · Cited by 3
Clinical heterogeneity within the ALS‐FTD spectrum in a family with a homozygous optineurin mutation
Parvizi, T., Klotz, S., Keritam, O., Caliskan, H., Imhof, S., König, T., Haider, L., Traub‐Weidinger, T., Wagner, M., Brunet, T., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52075 · Cited by 4
Genetics and ALS: Cause for Optimism.
Pochet, R. (2017) · PubMed Central · Cited by 3
Genetic Risk Factors for Sporadic Frontotemporal Dementia
Ferrari, R., Manzoni, C., & Momeni, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_9 · Cited by 3
β-Arrestin2 arrests the clearance of tau in FTLD
Thathiah, A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2001455117 · Cited by 3
Koçoğlu, C., Ferrari, R., Roes, M., Vandeweyer, G., Kooy, R. F., Broeckhoven, C. V., Manzoni, C., & van der Zee, J. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.018 · Cited by 3
Comment on “Cutting Edge: Inhibiting TBK1 by Compound II Ameliorates Autoimmune Disease in Mice”
Brenner, D., Andersen, P. M., Ludolph, A. C., & Weishaupt, J. H. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502255 · Cited by 3
Mutation TBK1 : un argument majeur pour le rôle de l’autophagie dans la SLA
Corcia, P., Beltran, S., Vourc’h, P., Meininger, V., & Couratier, P. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.10.004 · Cited by 3
Wider, C. W., Jasińska‐Myga, B., Konno, T., & Wszołek, Z. K. (2017) · Neurodegeneration · doi:10.1002/9781118661895.ch12 · Cited by 3
Almaguer-Mederos, L. E., Kandi, A. R., Şen, N.-E., Canet-Pons, J., Berger, L.-M., Key, J., Brunstein, M. E., Münch, C., Gispert, S., & Auburger, G. W. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.06.622233 · Cited by 3
Anjum, F., Hulbah, M. J., Shamsi, A., & Mohammad, T. (2025) · Life · doi:10.3390/life15111665 · Cited by 2
Genetics and Epigenetics in the Neurodegenerative Disorders of the Central Nervous System
Fenoglio, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_1 · Cited by 2
Khatoon, F., Haque, S., Hashem, A. M., Mahmoud, A. B., Tashkandi, H., Mathkor, D. M., Harakeh, S., Alghamdi, B. S., & Kumar, V. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1023286 · Cited by 2
Manzoni, C., & Ferrari, R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_17 · Cited by 2
Lin, Z., Ibrahim, A. N., Brown, R. H., & Sreedharan, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00034-0 · Cited by 2
Approaches to Identify and Characterise MYO6-Cargo Interactions
O’Loughlin, T. A., Kendrick‐Jones, J., & Buß, F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38062-5_15 · Cited by 2
Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
(2021) · Frontiers research topics · doi:10.3389/978-2-88966-904-2 · Cited by 3
Cochran, J. N., McKinley, E., Cochran, M., Amaral, M. D., Moyers, B. A., Lasseigne, B. N., Gray, D. E., Lawlor, J. M. J., Prokop, J. W., Geier, E. G., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/748046 · Cited by 2
Vicente, C. T., Niranjan, T., Coopman, E., Faura, J., Alidadiani, S., Schrauwen, C., Matchett, B. J., Heeman, B., den Broeck, M. V., Coster, W. D., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00869-2 · Cited by 1
Self-citationLin, C., Lee, B.-C., Zhang, P.-H., Lu, S.-C., Chang, W.-W., Wang, C., & Tsai, H. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00806 · Cited by 1
Geneticsof frontotemporal dementia and related disorders
Cruts, M., & Broeckhoven, C. V. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781316091586.017 · Cited by 1
Kacem, I., Sghaier, I., Peverelli, S., Abida, Y., Brahim, H. B., Ratti, A., Nasri, A., Ticozzi, N., Silani, V., & Gouider, R. (2023) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2023.2273961 · Cited by 1
Genetic contributions to sporadic frontotemporal dementia
Carr, J. S., Sirkis, D. W., & Yokoyama, J. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00005-0 · Cited by 1
Something old, something new: TBK1, a novel gene in known amyotrophic lateral sclerosis pathways
Farhan, S. M. K. (2015) · Clinical Genetics · doi:10.1111/cge.12624
Edbauer, D., & Arzberger, T. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1422-4
Future Prospects of Genome Sequencing
Sharma, S. (2016) · Research and reviews : journal of medical and health sciences/Research an reviews : journal of medical and health sciences
Gene Discovery in Mendelian and Complex Diseases
Farhan, S. M. K. (2016) · Scholarship@Western (Western University)
Autosomal Dominant Frontotemporal Lobar Degeneration: From Genotype to Phenotype
Serpente, M., & Galimberti, D. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_8
XI Convegno Nazionale: Firenze, 17–19 marzo 2016, Palazzo dei Congressi – Villa Vittoria
(2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-169001
Uncovering active modulators of native macroautophagy through novel high-content screensPreprint
Safren, N., Tank, E., Santoro, N., & Barmada, S. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/756973
Kasahara, S., Ishihara, T., Koike, Y. M., Sugai, A., & Onodera, O. (2020) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001362
Regulation of intracellular traffic by TBK1 and its relevance to ALS
Villarroel‐Campos, D. (2020) · UCL Discovery (University College London)
Clinical Heterogeneity of ALS – Implications for Models and Therapeutic Development
Lattante, S., & Sabatelli, M. (2021) · Wiley eBooks · doi:10.1002/9781119745532.ch1
Zhao, X. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737211509.793579398
Renton, A. E., & Goate, A. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0051
Oyston, L. J., Boccanfuso, L. M., Fitzpatrick, L., Zhang, J., Hallupp, M., Kwok, J. B., & Dobson‐Stone, C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.02.494603
Analysis of Adult Hippocampal Neurogenesis in Neurodegenerative disease
HAN, G. (2022) · Cronfa (Swansea University) · doi:10.23889/suthesis.62147
Analysis of “clinical exome” panel in Serbian patients with cognitive disorders
Branković, M., Stefanova, E. D., Mandić, G., Marjanović, A., Dobričić, V., Maver, A., Bergant, G., Stević, Z., Janković, M. Z., Novaković, I. V., et al. (2022) · Genetika · doi:10.2298/gensr2203351b
Estrada-Rodriguez, H. A., Meza-Martínez, D. A., Muñuzuri-Camacho, M. A., Garcia-Romero, D., & Reyes-Melo, I. (2023) · Cureus · doi:10.7759/cureus.43954
Sugai, A., Yamagishi, T., Koide, S., & Onodera, O. (2023) · Springer eBooks · doi:10.1007/978-981-99-4886-4_13
Sawyer, R. P., Doran, S., & Miller, B. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00032-7
Autophagy and Neurodegenerative Diseases
Barbosa, A. D., Palmer, J. E., Li, X., & Rubinsztein, D. C. (2025) · Learning materials in biosciences · doi:10.1007/978-3-031-88121-3_6
Argelazi, R. L., Graça, S. C., Thomazoni, P. V., Moura, C. B., Gomes, A. C. G., Kormanski, M. K., de Almeida, S. S. C., Ferreira, Y. D., & Santos, D. H. (2025) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2024-0227
Metadata
- Authors
- Pottier, C., Bieniek, K. F., Finch, N., van de Vorst, M., Baker, M., Perkersen, R., Brown, P., Ravenscroft, T., van Blitterswijk, M., Nicholson, A. M., DeTure, M., Knopman, D. S., Josephs, K. A., Parisi, J. E., Petersen, R. C., Boylan, K. B., Boeve, B. F., Graff-Radford, N. R., Veltman, J. A., Gilissen, C., Murray, M. E., Dickson, D. W., & Rademakers, R.
- Affiliations
- Mayo Clinic (US)
- Radboud University Nijmegen (NL)
- Corresponding author
- Rademakers, Rosa
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2015-05-06
- Volume
- 130
- Issue
- 1
- Pages
- 77-92
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC4470809
- OpenAlex
- W239648239
- Cited by
- 312
- References
- 63
- Citations by year
- 2026: 8 · 2025: 21 · 2024: 14 · 2023: 18 · 2022: 16 · 2021: 32 · 2020: 48 · 2019: 32 · 2018: 38 · 2017: 34 · 2016: 37 · 2015: 14
- FWCI
- 28.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- PubMed Central (acceptedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- National Institutes of Health (R01 AG037491, R01 NS076471, R01 NS080882, R01 AG026251, P50 AG016574, U01 AG006786)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- frontotemporal dementia, optineurin, TBK1, loss-of-function mutations, compound heterozygosity, copy number variation, single nucleotide variants, oligogenic inheritance, amyotrophic lateral sclerosis
- MeSH terms
- Aged, Aged, 80 and over, Brain, Female, Humans, Immunohistochemistry, Male, Mutation, RNA, Messenger, Blotting, Western, Cohort Studies, Gene Expression, Motor Neuron Disease, Protein Serine-Threonine Kinases, Sequence Analysis, DNA, Cell Cycle Proteins, Membrane Transport Proteins, Transcription Factor TFIIIA, DNA Copy Number Variations, Frontotemporal Lobar Degeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review